EP2940124A4 - NEW LACTOBACILLUS AND NEW MEDICINE, FOOD PRODUCT, BEVERAGE AND FEED CONTAINING LACTOBACILLUS - Google Patents

NEW LACTOBACILLUS AND NEW MEDICINE, FOOD PRODUCT, BEVERAGE AND FEED CONTAINING LACTOBACILLUS

Info

Publication number: EP2940124A4
Authority: EP; European Patent Office
Prior art keywords: lactobacillus; new; beverage; food product; feed containing
Prior art date: 2013-07-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

EP14823722.5A

Other languages

German (de)

French (fr)

Other versions

EP2940124A1 (en

EP2940124B1 (en

Inventor

Tomohiro Tanaka

Noriyuki Iwabuchi

Yohei Sato

Kanetada Shimizu

Toshitaka Odamaki

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Morinaga Milk Industry Co Ltd

Original Assignee

Morinaga Milk Industry Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-07-12

Filing date

2014-03-18

Publication date

2016-11-16

2014-03-18 Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd

2014-03-18 Priority to PL14823722T priority Critical patent/PL2940124T3/en

2015-11-04 Publication of EP2940124A1 publication Critical patent/EP2940124A1/en

2016-11-16 Publication of EP2940124A4 publication Critical patent/EP2940124A4/en

2017-12-13 Application granted granted Critical

2017-12-13 Publication of EP2940124B1 publication Critical patent/EP2940124B1/en

Status Active legal-status Critical Current

2034-03-18 Anticipated expiration legal-status Critical

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Polymers & Plastics (AREA)
Biotechnology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Food Science & Technology (AREA)
Mycology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Virology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Animal Husbandry (AREA)
Physiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Nutrition Science (AREA)
Immunology (AREA)
Pulmonology (AREA)
Tropical Medicine & Parasitology (AREA)
General Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Sustainable Development (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Fodder In General (AREA)

EP14823722.5A 2013-07-12 2014-03-18 Novel lactic acid bacterium, drug, food or drink, and feed which contain the novel lactic acid bacterium Active EP2940124B1 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
PL14823722T PL2940124T3 (en)	2013-07-12	2014-03-18	Novel lactic acid bacterium, drug, food or drink, and feed which contain the novel lactic acid bacterium

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2013146319		2013-07-12
PCT/JP2014/057319 WO2015004949A1 (en)	2013-07-12	2014-03-18	Novel lactobacillus and novel lactobacillus-containing medicine, food, beverage and feed

Publications (3)

Publication Number	Publication Date
EP2940124A1 EP2940124A1 (en)	2015-11-04
EP2940124A4 true EP2940124A4 (en)	2016-11-16
EP2940124B1 EP2940124B1 (en)	2017-12-13

Family

ID=52279648

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP14823722.5A Active EP2940124B1 (en)	2013-07-12	2014-03-18	Novel lactic acid bacterium, drug, food or drink, and feed which contain the novel lactic acid bacterium

Country Status (14)

Country	Link
US (3)	US20160114024A1 (en)
EP (1)	EP2940124B1 (en)
KR (1)	KR101614262B1 (en)
CN (1)	CN105579574B (en)
AU (1)	AU2014288647B8 (en)
BR (1)	BR112015024330A2 (en)
CA (1)	CA2897722C (en)
ES (1)	ES2660813T3 (en)
HU (1)	HUE036025T2 (en)
MX (1)	MX340355B (en)
MY (1)	MY178300A (en)
PL (1)	PL2940124T3 (en)
RU (1)	RU2607370C1 (en)
WO (1)	WO2015004949A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN107802657A (en) *	2016-09-08	2018-03-16	山东农业大学	Inactivate application of the lactic acid bacteria in porcine viral diseases medicine is prevented and treated
US11213555B2 (en) *	2016-09-08	2022-01-04	Weifang Huaying Biotechnology Co., Ltd.	Intravenous injection for enhancing immune function
CN107802658A (en) *	2016-09-08	2018-03-16	山东农业大学	Inactivate application of the lactic acid bacteria in poultry viral disease medicine is prevented and treated
CN107802653A (en) *	2016-09-08	2018-03-16	潍坊华英生物科技有限公司	Inactivate application of the lactic acid bacteria in tumor disease medicine is prevented and treated
CN107802651A (en) *	2016-09-08	2018-03-16	潍坊华英生物科技有限公司	Inactivate application of the lactic acid bacteria in viral disease medicine is prevented and treated
CN107802655A (en) *	2016-09-08	2018-03-16	潍坊华英生物科技有限公司	Inactivate application of the lactic acid bacteria in prevention and control sow vertical transmission disease medicament
CN107802656A (en) *	2016-09-08	2018-03-16	山东农业大学	Inactivate application of the lactic acid bacteria in canine viral disease medicine is prevented and treated
CN107802659B (en) *	2016-09-08	2020-08-25	潍坊华英生物科技有限公司	Intravenous injection for enhancing immunologic function
JP6815410B2 (en) *	2016-10-21	2021-01-20	森永乳業株式会社	Mood profile improver
JP7208894B2 (en) *	2017-05-23	2023-01-19	森永乳業株式会社	Cosmetics and skin protection agents containing lactic acid bacteria
CN107982523A (en) *	2018-01-17	2018-05-04	郑州赛科药业科技有限公司	A kind of compound Chinese medicinal preparation for livestock and poultry influenza and preparation method thereof
TWI746955B (en) *	2018-04-25	2021-11-21	日商曾根農場股份有限公司	Composition for Type I Allergy
MX2020011916A (en) *	2018-05-09	2021-04-13	Ko Biolabs Inc	LACTOBACILLUS PARACASEI STRAIN AND USE THEREOF.
CN110964658B (en) *	2018-09-30	2021-07-06	内蒙古伊利实业集团股份有限公司	Lactobacillus paracasei ET-22 with immunoregulation function
WO2020063531A1 (en)	2018-09-30	2020-04-02	内蒙古伊利实业集团股份有限公司	Lactobacillus paracasei et-22 and use thereof
CN113164772A (en) *	2018-12-07	2021-07-23	森永乳业株式会社	Composition for inhibiting norovirus infection
JP7333732B2 (en) *	2019-09-06	2023-08-25	森永乳業株式会社	A composition for maintaining muscle mass and/or muscle strength, or suppressing a decrease in muscle mass and/or muscle strength, and a pharmaceutical composition and a food/drink composition using the composition
CN111062344B (en) *	2019-12-20	2024-04-23	京东方科技集团股份有限公司	Ultrasonic fingerprint recognition method, device and system, display device, storage medium
TWI805237B (en) *	2020-05-06	2023-06-11	葡萄王生技股份有限公司	Use of lactic acid bacteria for manufacturing an antiviral composition
TWI757735B (en) *	2020-05-06	2022-03-11	葡萄王生技股份有限公司	Use of lactic acid bacteria for manufacturing an antiviral composition
CN113142301B (en) *	2021-01-18	2023-08-08	重庆市天友乳业股份有限公司	Dairy product capable of improving immunity of organism and preparation method thereof
JP2024505539A (en)	2021-02-01	2024-02-06	エムディーヘルスケアインコーポレイテッド	A composition for preventing, treating, or improving a viral infectious disease or respiratory disease containing Lactobacillus paracasei-derived vesicles
CN113892609B (en) *	2021-09-30	2023-07-21	华中农业大学	A Pickling Method for Improving the Quality of Liuzhou Sour Bamboo Shoots
KR20250004416A (en) *	2023-06-29	2025-01-08	재단법인 아산사회복지재단	Novel Lactobacillus paracasei and the use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20100196341A1 (en) *	2009-02-05	2010-08-05	Syngen Biotech Co., Ltd.	Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040047849A1 (en)	2002-09-11	2004-03-11	Genmont Biotech Inc.	Use of some lactobacillus strains in treating allergy
JP4847038B2 (en)	2005-04-11	2011-12-28	ゲンモントバイオテックインコーポレイティド	Novel microbial strain GM-080 of Lactobacillus paracasei and its use for treating allergy related diseases
AU2006297896B2 (en) *	2005-10-06	2011-12-08	Probi Ab	Use of lactobacillus for treatment of autoimmune diseases
JP2008245569A (en)	2007-03-30	2008-10-16	Kirin Holdings Co Ltd	Lactic acid bacteria composition having high antiallergic activity and method for producing the lactic acid bacteria
WO2009005124A1 (en)	2007-07-04	2009-01-08	Kikkoman Corporation	Double-stranded rna originating in lactic acid bacterium
JP5209294B2 (en)	2007-12-25	2013-06-12	株式会社ヤクルト本社	Interleukin 12 production promoter
FR2930264B1 (en)	2008-04-18	2013-02-22	Gervais Danone Sa	NEW STRAIN OF LACTOBACILLUS PARACASEI SUBSP. PARACASEI WITH ANTIMICROBIAL AND IMMUNOMODULATORY PROPERTIES
JP2010095465A (en) *	2008-10-16	2010-04-30	House Wellness Foods Kk	Immunostimulating composition containing lactic acid bacterium
US8765706B2 (en)	2009-09-02	2014-07-01	Kyoto Prefectural Public University Corporation	Composition comprising rna derived from lactic acid bacterium as effective component
KR101178217B1 (en)	2009-10-28	2012-09-07	씨제이제일제당 (주)	Novel lactobacillus plantarum and compositions comprising the same
TWI418356B (en) *	2009-12-23	2013-12-11	Lytone Enterprise Inc	Lactobacillus paracasei strain lt12 as immunity regulatory agent
JP5261617B2 (en) *	2011-03-31	2013-08-14	森永乳業株式会社	Novel lactic acid bacteria and pharmaceuticals, foods and drinks, and feeds containing the novel lactic acid bacteria
ES2610994T3 (en)	2014-08-26	2017-05-04	Chr. Hansen A/S	Bifidobacterium animalis subsp. lactis for use in reducing abdominal pain in a postmenopausal woman

2014
- 2014-03-18 CA CA2897722A patent/CA2897722C/en active Active
- 2014-03-18 MX MX2015009897A patent/MX340355B/en active IP Right Grant
- 2014-03-18 MY MYPI2015001720A patent/MY178300A/en unknown
- 2014-03-18 EP EP14823722.5A patent/EP2940124B1/en active Active
- 2014-03-18 HU HUE14823722A patent/HUE036025T2/en unknown
- 2014-03-18 ES ES14823722.5T patent/ES2660813T3/en active Active
- 2014-03-18 AU AU2014288647A patent/AU2014288647B8/en active Active
- 2014-03-18 KR KR1020157019036A patent/KR101614262B1/en active Active
- 2014-03-18 PL PL14823722T patent/PL2940124T3/en unknown
- 2014-03-18 CN CN201480010045.5A patent/CN105579574B/en active Active
- 2014-03-18 BR BR112015024330A patent/BR112015024330A2/en not_active Application Discontinuation
- 2014-03-18 WO PCT/JP2014/057319 patent/WO2015004949A1/en not_active Ceased
- 2014-03-18 RU RU2015135355A patent/RU2607370C1/en active
- 2014-03-18 US US14/759,124 patent/US20160114024A1/en not_active Abandoned
2016
- 2016-09-09 US US15/261,548 patent/US10064903B2/en active Active
2018
- 2018-08-20 US US16/105,467 patent/US10653730B2/en active Active

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20100196341A1 (en) *	2009-02-05	2010-08-05	Syngen Biotech Co., Ltd.	Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
G. JAHREIS ET AL: "Influence of probiotic sausage (Lactobacillus paracasei) on blood lipids and immunological parameters of healthy volunteers", FOOD RESEARCH INTERNATIONAL, vol. 35, 1 January 2002 (2002-01-01), pages 133 - 138, XP055306558 *

Also Published As

Publication number	Publication date
CN105579574B (en)	2017-08-25
US20170007650A1 (en)	2017-01-12
AU2014288647A1 (en)	2015-07-23
PL2940124T3 (en)	2018-05-30
EP2940124A1 (en)	2015-11-04
CN105579574A (en)	2016-05-11
US20180353557A1 (en)	2018-12-13
US10064903B2 (en)	2018-09-04
US20160114024A1 (en)	2016-04-28
KR20150090258A (en)	2015-08-05
RU2607370C1 (en)	2017-01-10
BR112015024330A2 (en)	2017-07-18
HUE036025T2 (en)	2018-06-28
EP2940124B1 (en)	2017-12-13
AU2014288647B2 (en)	2015-09-24
MX2015009897A (en)	2015-09-24
WO2015004949A1 (en)	2015-01-15
MX340355B (en)	2016-07-06
CA2897722C (en)	2016-07-12
KR101614262B1 (en)	2016-04-20
US10653730B2 (en)	2020-05-19
AU2014288647B8 (en)	2015-10-29
ES2660813T3 (en)	2018-03-26
MY178300A (en)	2020-10-07
CA2897722A1 (en)	2015-01-15

Publication	Publication Date	Title
EP2940124A4 (en)	2016-11-16	NEW LACTOBACILLUS AND NEW MEDICINE, FOOD PRODUCT, BEVERAGE AND FEED CONTAINING LACTOBACILLUS
IL279001A (en)	2021-01-31	Nasal drug products and methods of their use
EP3185727A4 (en)	2018-08-22	Food product dispenser and valve
EP3122407A4 (en)	2018-01-03	Devices and methods for packaging and dispensing unit doses of personal care products
ZA201604616B (en)	2019-11-27	Food product and method of preparation
GB201421215D0 (en)	2015-01-14	A food product and methods of packaging raw wet protein for retail
PL3204312T3 (en)	2019-05-31	Packages containing a food product and method of opening
IL249713A0 (en)	2017-02-28	Inter-operable capsule dispensing unit and beverage preparation machine
PT3295993T (en)	2020-01-21	Device for the administration of a cosmetic product, corresponding process, use and container
ZA201704692B (en)	2018-11-28	Novel compounds, synthesis method thereof and use of same in medicine and in cosmetics
HUE043174T2 (en)	2019-08-28	Administration of a food composition product
IL249714A0 (en)	2017-02-28	Inter-operable capsule dispensing unit and beverage preparation machine
LT3215118T (en)	2021-06-10	QUINAGOLIDE CONTAINING MEDICINAL PRODUCT AND MEDICINAL PRODUCT KIT
PL3185730T3 (en)	2022-11-14	Improvements in machines for the preparation of beverage and liquid food products
FR3002209B1 (en)	2016-01-08	PACKAGING, IN PARTICULAR FOR A FOOD PRODUCT, AND CORRESPONDING CONTAINER
IL250418A0 (en)	2017-03-30	Use in one pill / tablet / capsule minocycline, acicloguanosin, atorvastatin and vitamin d in the treatment of rheumatoid arthritis
EP3162350A4 (en)	2018-04-04	Pharmaceutical product container and pharmaceutical preparation
IL250419A0 (en)	2017-03-30	Use in single pill/tablet/capsule of minocycline, fluconazole and atorvastatin in the treatment of multiple sclerosis
EP3266765A4 (en)	2018-09-05	Boron-dipyrrin complex and pharmaceutical product containing same
PT3092183T (en)	2018-02-12	Article including a bottle of cosmetic product and a pack
GB2530339B (en)	2018-08-15	Packaging for containing and displaying products
PT3134328T (en)	2018-10-31	Capsule for infusion products, in particular coffee
GB201711713D0 (en)	2017-09-06	Food product comprising inulin and konjac mannan
GB201305999D0 (en)	2013-05-15	Container for a food product, beverage or pharmaceutical product
PL3136357T3 (en)	2019-04-30	Bulk product dispenser and corresponding method of use

Legal Events

Date	Code	Title	Description
2015-10-02	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2015-11-04	17P	Request for examination filed	Effective date: 20150731
2015-11-04	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2015-11-04	AX	Request for extension of the european patent	Extension state: BA ME
2016-10-19	DAX	Request for extension of the european patent (deleted)
2016-11-16	A4	Supplementary search report drawn up and despatched	Effective date: 20161014
2016-11-16	RIC1	Information provided on ipc code assigned before grant	Ipc: A23K 10/18 20160101ALN20161010BHEP Ipc: A61P 31/12 20060101ALI20161010BHEP Ipc: A61K 39/145 20060101ALN20161010BHEP Ipc: A23K 10/16 20160101ALN20161010BHEP Ipc: C12R 1/225 20060101ALN20161010BHEP Ipc: A61K 39/00 20060101ALN20161010BHEP Ipc: A23K 10/12 20160101ALN20161010BHEP Ipc: A61K 35/74 20150101ALI20161010BHEP Ipc: C12N 1/20 20060101AFI20161010BHEP Ipc: A23L 33/135 20160101ALN20161010BHEP Ipc: A61K 35/747 20150101ALI20161010BHEP Ipc: A23L 2/52 20060101ALN20161010BHEP Ipc: A61P 37/04 20060101ALI20161010BHEP Ipc: A61P 31/16 20060101ALI20161010BHEP Ipc: A61K 35/00 20060101ALN20161010BHEP Ipc: A23L 33/10 20160101ALI20161010BHEP
2017-05-10	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 35/00 20060101ALN20170404BHEP Ipc: A61P 37/04 20060101ALI20170404BHEP Ipc: A61K 39/145 20060101ALN20170404BHEP Ipc: A23K 10/16 20160101ALN20170404BHEP Ipc: A23L 2/52 20060101ALN20170404BHEP Ipc: C12N 1/20 20060101AFI20170404BHEP Ipc: A23K 10/18 20160101ALN20170404BHEP Ipc: A23K 10/12 20160101ALN20170404BHEP Ipc: A61K 35/747 20150101ALI20170404BHEP Ipc: A23L 33/10 20160101ALI20170404BHEP Ipc: C12R 1/225 20060101ALN20170404BHEP Ipc: A23L 33/135 20160101ALN20170404BHEP Ipc: A61K 39/00 20060101ALN20170404BHEP Ipc: A61P 31/12 20060101ALI20170404BHEP Ipc: A61P 31/16 20060101ALI20170404BHEP Ipc: A61K 35/74 20150101ALI20170404BHEP
2017-05-22	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2017-06-21	INTG	Intention to grant announced	Effective date: 20170523
2017-06-21	RIN1	Information on inventor provided before grant (corrected)	Inventor name: SATO, YOHEI Inventor name: SHIMIZU, KANETADA Inventor name: IWABUCHI, NORIYUKI Inventor name: ODAMAKI, TOSHITAKA Inventor name: TANAKA, TOMOHIRO
2017-10-02	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2017-11-08	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: MORINAGA MILK INDUSTRY CO., LTD.
2017-11-08	RIN1	Information on inventor provided before grant (corrected)	Inventor name: IWABUCHI, NORIYUKI Inventor name: ODAMAKI, TOSHITAKA Inventor name: SHIMIZU, KANETADA Inventor name: TANAKA, TOMOHIRO Inventor name: SATO, YOHEI
2017-11-10	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2017-12-13	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D
2017-12-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: REF Ref document number: 954380 Country of ref document: AT Kind code of ref document: T Effective date: 20171215 Ref country code: CH Ref legal event code: EP
2018-01-10	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2018-01-18	REG	Reference to a national code	Ref country code: DE Ref legal event code: R096 Ref document number: 602014018599 Country of ref document: DE
2018-03-07	REG	Reference to a national code	Ref country code: NL Ref legal event code: FP
2018-03-26	REG	Reference to a national code	Ref country code: ES Ref legal event code: FG2A Ref document number: 2660813 Country of ref document: ES Kind code of ref document: T3 Effective date: 20180326
2018-03-27	REG	Reference to a national code	Ref country code: FR Ref legal event code: PLFP Year of fee payment: 5
2018-04-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180313 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213
2018-05-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: MK05 Ref document number: 954380 Country of ref document: AT Kind code of ref document: T Effective date: 20171213
2018-05-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180314 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180313 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213
2018-06-28	REG	Reference to a national code	Ref country code: HU Ref legal event code: AG4A Ref document number: E036025 Country of ref document: HU
2018-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213
2018-08-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180413 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213
2018-09-14	REG	Reference to a national code	Ref country code: DE Ref legal event code: R097 Ref document number: 602014018599 Country of ref document: DE
2018-10-19	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2018-10-19	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2018-10-31	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2018-11-21	26N	No opposition filed	Effective date: 20180914
2018-11-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213
2018-12-26	REG	Reference to a national code	Ref country code: IE Ref legal event code: MM4A
2018-12-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180318
2019-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180318
2019-02-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180331 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180331
2020-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180318
2020-03-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213
2020-05-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213
2020-06-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: MK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171213
2020-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213
2023-06-21	P01	Opt-out of the competence of the unified patent court (upc) registered	Effective date: 20230517
2025-04-11	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: DE Payment date: 20250331 Year of fee payment: 12
2025-04-15	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: NL Payment date: 20250314 Year of fee payment: 12
2025-04-17	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: HU Payment date: 20250327 Year of fee payment: 12
2025-04-24	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: BE Payment date: 20250314 Year of fee payment: 12
2025-04-25	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: PL Payment date: 20250312 Year of fee payment: 12 Ref country code: FR Payment date: 20250312 Year of fee payment: 12
2025-04-28	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: IT Payment date: 20250314 Year of fee payment: 12 Ref country code: GB Payment date: 20250327 Year of fee payment: 12
2025-07-10	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: ES Payment date: 20250409 Year of fee payment: 12